miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis

Figure 6

miR-20b affected T cells partially through NFAT5 and CAMTA. (a) NFAT5 expression was determined in siR-control + anti-miR-NC, siR-NFAT5 + anti-miR-NC, and siR-NFAT5 + anti-miR-20b group. MTT cell proliferation (b) and qRT-PCR analysis of IL-2 (c) and IL-10 (d) expression were performed in Jurkat cells. (e) AMTA1 expression was determined in siR-control + anti-miR-NC, siR-CAMTA1 + anti-miR-NC, and siR-CAMTA1 + anti-miR-20b groups. MTT cell proliferation (f) and qRT-PCR analysis of IL-2 (g) and IL-10 (h) expression were performed in Jurkat cells. .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)